Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, Pablo Castro, Pelagia Tsoutsou, Karin Stellamans, Adnan Shaukat, Miha Orazem, Paul Jeene, Pètra Braam, Helena Verkooijen, Inga-Malin Simek, Filippo Alongi, Enrico Clementel, Catherine Fortpied, Abigirl Machingura, Felix Boakye Oppong, Matthias Guckenberger, Piet Ost
OBJECTIVE: To evaluate the impact of metastases-directed stereotactic body radiotherapy (SBRT) on health-related quality of life (HRQoL) in men with oligometastatic prostate cancer (PCa) using real-world data from the OligoCare cohort. MATERIALS AND METHODS: OligoCare is a pragmatic, observational cohort designed to assess the impact of metastases-directed SBRT on patients with oligometastatic disease (OMD). We report an interim analyses of the secondary endpoint HRQoL, assessed using the EORTC QLQ-C30, within six months of metastases-directed SBRT for oligometastatic disease in men with PCa among the first 1600 registered patients...
March 2024: Clinical and Translational Radiation Oncology